MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
672.05%
Quick Ratio
672.05%
Cash Ratio
77.78%
Unit: Thousand (K) dollars
Assets Breakdown
Marketable securities
Cash and cash equivalents
Prepaid expenses and other asset...
Others
Liabilities Breakdown
Total shareholders equity
Total current liabilities
Total non-current liabilities
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
5,129
4,868
15,647
3,326
Marketable securities
38,375
46,463
44,243
51,992
Prepaid expenses and other assets
567
731
481
445
Amounts receivable
244
301
258
260
Deposits
-
-
-
200
Total current assets
44,315
52,363
60,629
56,223
Deferred offering costs
400
400
400
456
Operating lease right-of-use asset
153
175
197
218
Property, plant and equipment, gross
297
301
295
289
Less accumulated depreciation
164
159
150
139
Property and equipment, net
133
142
145
150
Deposits
-
-
0
0
Total non-current assets
686
717
742
824
Total assets
45,001
53,080
61,371
57,047
Accounts payable
2,812
3,293
1,475
1,920
Accrued liabilities
3,666
2,340
3,545
3,239
Operating lease obligation
107
104
101
99
Finance lease obligation
9
11
11
10
Total current liabilities
6,594
5,748
5,132
5,268
Operating lease obligation
69
96
124
150
Finance lease obligation, non-current
0
1
4
7
Total non-current liabilities
69
97
128
157
Paid-in capital
231,324
230,071
228,829
215,600
Accumulated other comprehensive income (loss)
-37
-26
50
50
Accumulated deficit
-192,949
-182,810
-172,768
-164,028
Total shareholders equity
38,338
47,235
56,111
51,622
Total liabilities and shareholders equity
45,001
53,080
61,371
57,047
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Property, plant and
equipment, gross
$297K
(6.07%↑ Y/Y)
Marketable securities
$38,375K
(48.00%↑ Y/Y)
Cash and cash
equivalents
$5,129K
(24.82%↑ Y/Y)
Prepaid expenses and
other assets
$567K
(-16.62%↓ Y/Y)
Amounts receivable
$244K
(51.55%↑ Y/Y)
Deferred offering costs
$400K
Operating lease
right-of-use asset
$153K
(-35.98%↓ Y/Y)
Property and equipment,
net
$133K
(-12.50%↓ Y/Y)
Less accumulated
depreciation
$164K
(28.13%↑ Y/Y)
Total current assets
$44,315K
(42.59%↑ Y/Y)
Total non-current
assets
$686K
(75.45%↑ Y/Y)
Total assets
$45,001K
(43.00%↑ Y/Y)
Total liabilities and
shareholders equity
$45,001K
(43.00%↑ Y/Y)
Total shareholders
equity
$38,338K
(41.10%↑ Y/Y)
Total current
liabilities
$6,594K
(60.20%↑ Y/Y)
Total non-current
liabilities
$69K
(-62.50%↓ Y/Y)
Accumulated deficit
-$192,949K
(-24.16%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$37K
(-164.29%↓ Y/Y)
Paid-in capital
$231,324K
(26.69%↑ Y/Y)
Accrued liabilities
$3,666K
(33.45%↑ Y/Y)
Accounts payable
$2,812K
(123.00%↑ Y/Y)
Operating lease
obligation
$107K
(11.46%↑ Y/Y)
Finance lease
obligation
$9K
(-25.00%↓ Y/Y)
Operating lease
obligation
$69K
(-60.80%↓ Y/Y)
Buy us a coffee
DiaMedica Therapeutics Inc. (DMAC)
DiaMedica Therapeutics Inc. (DMAC)